Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Placebo Controlled Randomised Study of Aramchol on Liver Triglyceride in Patients With Steatosis Due to NAFLD or NASH

NCT01094158 is registered in ClinicalTrials.gov with Galmed Medical Reserch as lead sponsor.

NCT NCT01094158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01094158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Placebo Controlled Randomised Study of Aramchol on Liver Triglyceride in Patients With Steatosis Due to NAFLD or NASH
Lead sponsor
Galmed Medical Reserch
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2010
Completion date
January 31, 2012
Enrollment
60 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis